ペンシルベニアにおける間質性肺疾患の臨床試験
ペンシルベニア内の拠点で、間質性肺疾患に関する18件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Pennsylvania, Philadelphia
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/30更新 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA013, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Thomas Jefferson University, Philadelphia
- Temple Lung Center, Temple University, Philadelphia
- UPMC Montefiore, Pittsburgh
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/29更新 · NCT05798923A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05878717Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Thomas Jefferson University, Philadelphia
- Temple University of The Commonwealth System of Higher Education, Philadelphia
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632Dorothy P. and Richard P. Simmons Center for ILD Research Registry
- Michelle F MacPherson, Pittsburgh
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/27更新 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- St. Luke's University Health Network, Bethlehem
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
- 他2件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06195072Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第2相
8歳〜60歳 · 全性別 · 2026/08/14更新 · NCT03630211Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Temple University, Philadelphia
- Thomas Jefferson University, Philadelphia
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Temple University, Philadelphia
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/10更新 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Pennsylvania State Hershey Medical Center and College of Medicine, Hershey
- Hospital of the University of Pennsylvania, Philadelphia
- Jefferson Honickman Center, Philadelphia
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中観察研究
24歳以下 · 全性別 · 2026/06/22更新 · NCT04098445Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2026/04/21更新 · NCT05746039Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Temple University Hospital-Temple Lung Center, Philadelphia
被験者募集中第2相
40歳以上 · 全性別 · 2025/11/12更新 · NCT05975983ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。